🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesPrediabetes reversal on GLP-1 — my results so far Page 4

Prediabetes reversal on GLP-1 — my results so far

KarenAZ_mom Wed, Mar 5, 2025 at 2:11 PM 16 replies 1,721 viewsPage 4 of 4
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Mar 7, 2025 at 10:17 AM#16

From the other side of the consultation, briefly. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Mar 7, 2025 at 12:17 PM
22 20jennifer_SEA, tyler_CSCS, VanRx_Mike and 19 others
Reply Quote Save Share Report
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
Mar 7, 2025 at 12:21 PM#17
DanielChem_CHI said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.

23 21JakeSmashed95, NauseaFreeNow, SteveThurs and 20 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Mar 7, 2025 at 2:25 PM#18
DanielChem_CHI said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

Last edited: Mar 7, 2025 at 5:25 PM
24 22tommy_boulder, hyun_seoul, jim_asheville and 21 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Mar 7, 2025 at 4:29 PM#19

Clinical perspective, offered as context rather than as advice. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

25 23FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 22 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 7, 2025 at 6:33 PM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Thread quality here is what the rules are for. Keep it up.

47 20PurityPaulOR, MaxMetOK, MounjBrad and 44 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register